Correspondence 0001104659-22-125422 from FENNEC PHARMACEUTICALS INC. (FENC) (CIK 0001211583) (FENC)
FENNEC PHARMACEUTICALS INC. (FENC) (CIK 0001211583)
Date: Dec. 8, 2022 · CIK: 0001211583 · Accession: 0001104659-22-125422
AI Filing Summary & Sentiment
File numbers found in text: 333-268632
Letter
Fennec Pharmaceuticals Inc.
PO Box 13628, 68 TW Alexander Drive
Research Triangle Park, NC 27709
December 8, 2022
Via EDGAR Correspondence
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington D. C. 20549
Re: Acceleration of Effective Date
Fennec Pharmaceuticals Inc.
Registration Statement on Form S-3
File No. 333-268632
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 p.m., Eastern Time, on December 12, 2022, or as soon thereafter as is practicable.
Very truly yours,
FENNEC PHARMACEUTICALS INC.
Show Raw Text
CORRESP
1
filename1.htm
Fennec Pharmaceuticals Inc.
PO Box 13628, 68 TW Alexander Drive
Research Triangle Park, NC 27709
December 8, 2022
Via EDGAR Correspondence
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington D. C. 20549
Re:
Acceleration of Effective Date
Fennec Pharmaceuticals Inc.
Registration Statement on Form S-3
File No. 333-268632
Ladies and Gentlemen:
In accordance with Rule 461
under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration
Statement be accelerated so that the same will become effective at 4:00 p.m., Eastern Time, on December 12, 2022, or as soon thereafter
as is practicable.
Very truly yours,
FENNEC PHARMACEUTICALS INC.
By:
/s/ Rostislav Raykov
Rostislav Raykov
Chief Executive Officer